Explainer · eConsentUpdated October 15, 2026

What is eConsent? Electronic informed consent explained

eConsent moves the informed consent process onto a screen: the information, the conversation, the signature and the record. This guide explains what it is and is not, how a consent session works, what regulators say and how to pick a system. It is an explainer; the product pages cover specific features.

  • Definition and how it works
  • Regulatory picture in plain terms
  • Choosing and rolling out eConsent

Free sandbox · No credit card · 21 CFR Part 11 aligned

A typical eConsent session · demo
  1. Invitation

    Participant opens a link or scans a code

  2. Read

    Information shown in sections

  3. Discuss

    Questions asked and answered by staff

  4. 4

    Sign

    Participant signs on screen, identity confirmed

  5. 5

    Countersign

    Investigator or delegate signs

  6. 6

    Copy

    Participant receives a copy; record stored

Process shown for orientation. Your IRB or ethics committee approves the actual process.

eConsent in brief

  • Definition. eConsent is the use of electronic systems and media to give participants the information in a consent document, to document their agreement and to keep the record. It supports the consent process; it does not replace the conversation with the study team.
  • It is a process, not a PDF. A scanned paper form is not eConsent. The value comes from clearer presentation, controlled versions, identity checks, signatures and an audit trail.
  • Regulators allow it, with conditions. FDA and OHRP published joint Q&A on electronic informed consent (final December 2016). In the EU the position depends on the member state and ethics committee. Your IRB approves the process.
  • It can be on site or remote. The same system can be used at the clinic on a tablet or remotely with a video or phone call alongside.
  • Choose on controls and fit. Signature controls, identity checks, version control, exports, ethics-friendly review views and how it connects to your data system matter more than animations.

Definition

What eConsent is, and what it is not

Informed consent is the process through which a person learns about a study and voluntarily agrees to take part. It has always been more than a signature: the participant needs adequate information, time to consider, a chance to ask questions and freedom from pressure. A form documents that the process took place. eConsent keeps all of that and changes the medium.

In practice an eConsent system presents the participant information electronically, often in short sections with plain-language headings, sometimes with diagrams or video. It records that the participant has viewed the content, captures their signature (and the signature of the person who conducted the discussion), stores the exact version signed and produces a copy. Better systems add comprehension questions, identity verification, role-based access for staff and an audit trail.

It is not a substitute for human contact. Regulators and ethics committees expect that participants can ask questions and receive answers from someone knowledgeable. It is also not a data-protection decision: consent to participate in research is a different thing from a GDPR legal basis for processing personal data, which many trials handle separately.

Comparison

Paper consent and eConsent side by side

AspectPaper processeConsent
PresentationLong printed documentSections, headings, optional visuals, one version shown
Version controlRisk of an old form in a drawerSingle approved version shown, versions recorded
SignatureWet ink, initials per pageElectronic signature with identity and intent controls
CompletenessMissed initials or dates found at monitoringRequired steps enforced before completion
Copy to participantPhotocopyPDF generated at signing
Remote participationPost or courierPossible with the right identity and discussion process
Audit trailManual file reviewTime-stamped events stored with the record
Cost and effortPrinting, scanning, filingSet-up effort, then lower handling

Benefits depend on how well the process is designed and approved. A badly designed eConsent flow can be worse than a good paper one.

How it works

The anatomy of an eConsent session

  1. 1

    Prepare the document

    The study team writes the consent content (see how to write an eConsent form), the IRB or ethics committee approves it and the approved version is loaded into the system.

  2. 2

    Invite the participant

    The participant is given access by a link or code, in clinic or remotely. Their identity is checked in a way that suits the risk of the study.

  3. 3

    Present the information

    Content is shown in sections. The participant can go back, and the system may log what was viewed.

  4. 4

    Hold the discussion

    The investigator or delegate talks with the participant, in person, by phone or by video, and answers questions. The system should let staff record that this took place.

  5. 5

    Capture signatures

    The participant signs electronically and staff countersign. Some studies add a witness or a legally authorised representative.

  6. 6

    Store and share the record

    The signed document, signature data, timestamps and version are kept. The participant receives a copy.

  7. 7

    Link to the study record

    The consent status should be visible to site staff before screening procedures, and ideally sit beside the participant's data in the same system.

See an eConsent flow with your own wording

Load a consent template, walk through a test session and export the signed PDF. The free sandbox has every feature, with no credit card and no time limit.

Try an eConsent flow free

Regulation

What regulators say, in plain terms

This is a summary; the details and your obligations depend on where the study runs. For the regulation texts mapped in detail, read the electronic informed consent regulations guide.

United States. FDA and the HHS Office for Human Research Protections issued joint "Use of Electronic Informed Consent: Questions and Answers" (final December 2016). It explains that electronic consent can meet the requirements of the regulations for informed consent and IRB review and that, where FDA rules apply, electronic signatures should come from systems that meet Part 11 expectations. FDA also has a general informed consent guidance (August 2023) and a Q&A on electronic systems, records and signatures in clinical investigations (final October 2024). Check the current texts.

European Union. The Clinical Trials Regulation sets principles for informed consent, and member states and ethics committees apply them. A recommendation paper on decentralised elements published by EMA, HMA and the Commission in December 2022 discusses electronic consent but is not binding. Ask the ethics committee in each country what it accepts, particularly for remote signatures.

Good clinical practice. ICH E6 requires that the consent process and documents are approved and that the participant is informed before taking part. Treat the current E6 text as the baseline, and see ICH E6(R3) for clinical trial teams.

Data protection. Where GDPR applies, you also need a lawful basis for processing personal data and clear information about it. This is a separate decision from the participation consent.

Choosing

How to choose an eConsent system

Start from your process and your ethics committee, then compare systems against a short list of requirements. The best-looking demo is not the best choice if the signature controls are weak or the record cannot be exported. For a shortlist, see best eConsent software and the buying view in eConsent software for clinical trials.

A short requirements list

Ask each vendor, and test in a sandbox:

  • How is the participant's identity confirmed, and how is signature intent captured?
  • Is the signed record tied to the exact document version and protected from change?
  • Can staff countersign with re-authentication, and can a witness or representative sign when needed?
  • Does the audit trail record who did what and when, and can it be exported?
  • Can the IRB review the exact screens, and can you control versions?
  • Does consent status sit next to the study data, or in a separate system you must reconcile?
  • Which languages and reconsent workflows are supported today? Ask for the current status in writing.

How Capture handles the core controls

Capture eConsent is part of the same platform as EDC and ePRO. See the Capture eConsent product page for the full feature description. In outline:

  • On-screen signature verified by a mandatory email one-time code, after the participant acknowledges the legal-binding statement.
  • Staff countersignature with password re-authentication; optional witness and legally authorised representative signatures.
  • Each signature is hashed to the exact document content at the time of signing.
  • Signed consent exports as a PDF with signature data, timestamps and audit trail.
  • Consent templates for basic trials, pediatric assent, biobanks and more, starting at the basic consent template.
Electronic signature

Meaning of signature

I have reviewed this adverse event and confirm the assessment of seriousness, severity and causality.

Signer

Dr. A. Ozola, PI

Password

••••••••••

Verified on the serverAutofill blockedSingle-use token
Sign

Rollout

Introducing eConsent without surprises

Tell the ethics committee early

Describe the process, identity checks and the screens, and ask for feedback before final submission.

Keep the conversation central

Train staff to use the system as a support for discussion, not as a replacement for it.

Offer a paper option

Some participants prefer paper. Decide whether your study allows it and how both routes are recorded.

Test with real wording

Run test consents from start to finish, including countersignature and export.

Control versions

Record which participant signed which version and when a new version applies.

Plan the record keeping

Know where signed consents are stored and who can open them. See remote patient consent for remote workflows.

FAQ

Questions teams ask before they switch

Something not covered here? Ask us directly.

What is eConsent in clinical trials?

eConsent is the use of electronic systems to present informed consent information, capture the participant's and staff signatures, store the signed version and give the participant a copy. It supports the consent process rather than replacing the discussion with the study team.

Is eConsent legally valid?

It can be, when the process meets the applicable rules. In the US, FDA and OHRP have published Q&A explaining how electronic consent can satisfy the regulations. In the EU, acceptance depends on the member state and ethics committee. Your IRB or ethics committee approves the process.

Is eConsent the same as an e-signature?

No. A signature is one step. eConsent covers the information presentation, identity, discussion, signatures, version control and record keeping.

Does eConsent have to be remote?

No. Many studies use it on a tablet in clinic. It can also be used remotely when the identity and discussion steps are designed for it and approved.

Does 21 CFR Part 11 apply to eConsent?

For FDA-regulated studies, the joint Q&A says Part 11 generally applies where the consent and IRB regulations apply, so electronic signatures should come from a system with Part 11 controls. Confirm with your sponsor and IRB.

How much does eConsent cost?

It varies by vendor and model. Capture has a free sandbox and you pay when you go live with real participants; ask for terms in writing. See eConsent cost per study for what to count.

What is the difference between this guide and the Capture eConsent page?

This page explains the concept, regulation and selection. The Capture eConsent page describes the product features, signature workflow and templates.

Try eConsent with your own wording, free

Free sandbox with every feature. No credit card, and you pay only when you go live with real participants.

Try an eConsent flow free